New drug ZE74-0282 put to first safety test in humans
NCT ID NCT07527221
First seen Apr 19, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This early-stage study tests the safety of a single oral dose of ZE74-0282 in 40 healthy adults aged 18 to 55. Researchers will monitor for side effects and measure how the drug moves through the body. No treatment is given; the goal is to gather safety data before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Scientia Clinical Research Ltd.
Randwick, New South Wales, 2031, Australia
Conditions
Explore the condition pages connected to this study.